We are live on ! Find out more
KFS

Kurt F. Somerville Portfolio holdings

AUM $379M
1-Year Est. Return 19.42%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+19.42%
3 Year Est. Return
+62.7%
5 Year Est. Return
+83.65%
10 Year Est. Return
+302.17%
AUM
$445M
AUM Growth
+$6.84M
Cap. Flow
+$2.47M
Cap. Flow %
0.55%
Top 10 Hldgs %
38.58%
Holding
114
New
2
Increased
33
Reduced
33
Closed
4

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$2.24M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.7M
3
CB icon
Chubb
CB
+$1.56M
4
GILD icon
Gilead Sciences
GILD
+$1.49M
5
UL icon
Unilever
UL
+$784K

Sector Composition

Rank Sector Weight
1 Healthcare 24.37%
2 Technology 20.88%
3 Industrials 15.58%
4 Consumer Staples 10.8%
5 Financials 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXPI icon
26
NXP Semiconductors
NXPI
$68B
$5.29M 1.19%
67,485
-960
-1% -$82.3K
XLNX
27
DELISTED
Xilinx Inc
XLNX
$5.24M 1.18%
113,560
+4,700
+4% +$215K
TGT icon
28
Target
TGT
$62.1B
$5.17M 1.16%
74,051
+915
+1% +$68.3K
CSCO icon
29
Cisco
CSCO
$450B
$4.73M 1.06%
164,940
+1,190
+0.7% +$33.4K
JCI icon
30
Johnson Controls International
JCI
$87.5B
$4.29M 0.96%
92,474
-41,895
-31% -$1.85M
GE icon
31
GE Aerospace
GE
$367B
$3.95M 0.89%
26,166
+585
+2% +$85.3K
HP icon
32
Helmerich & Payne
HP
$3.53B
$3.94M 0.89%
58,791
-10,058
-15% -$621K
DHR icon
33
Danaher
DHR
$135B
$3.83M 0.86%
56,404
+34,176
+154% +$2.24M
GILD icon
34
Gilead Sciences
GILD
$161B
$3.58M 0.8%
42,863
+16,789
+64% +$1.49M
PRGO icon
35
Perrigo
PRGO
$1.4B
$3.43M 0.77%
37,801
-115
-0.3% -$11.9K
XYL icon
36
Xylem
XYL
$28.5B
$3.42M 0.77%
76,488
+4,910
+7% +$213K
CVX icon
37
Chevron
CVX
$388B
$3.33M 0.75%
31,737
-2,945
-8% -$296K
GIS icon
38
General Mills
GIS
$19.2B
$3.25M 0.73%
45,536
EMR icon
39
Emerson Electric
EMR
$82.9B
$3.17M 0.71%
60,843
-52,435
-46% -$2.79M
PBA icon
40
Pembina Pipeline
PBA
$29.9B
$2.91M 0.65%
95,950
-3,925
-4% -$115K
SJM icon
41
J.M. Smucker
SJM
$12.6B
$2.56M 0.58%
16,802
-10
-0.1% -$1.33K
ILMN icon
42
Illumina
ILMN
$29.4B
$2.52M 0.57%
18,448
+819
+5% +$116K
NVO
43
Novo Nordisk
NVO
$216B
$2.21M 0.5%
82,340
-200
-0.2% -$5.49K
QCOM icon
44
Qualcomm
QCOM
$176B
$2.2M 0.5%
41,174
-2,410
-6% -$127K
CL icon
45
Colgate-Palmolive
CL
$72.6B
$2.15M 0.48%
29,380
-50
-0.2% -$3.56K
MRK icon
46
Merck
MRK
$324B
$2.07M 0.46%
37,631
-1,257
-3% -$66.9K
ABBV icon
47
AbbVie
ABBV
$458B
$1.98M 0.45%
32,040
STT icon
48
State Street
STT
$50.9B
$1.7M 0.38%
31,504
-3,950
-11% -$236K
PFE icon
49
Pfizer
PFE
$140B
$1.61M 0.36%
48,126
-210
-0.4% -$6.7K
BMY icon
50
Bristol-Myers Squibb
BMY
$127B
$1.59M 0.36%
21,600
-150
-0.7% -$10.6K

Similar funds

Kurt F. Somerville's Q2 2016 Portfolio in Review

As of Q2 2016, Kurt F. Somerville held 114 positions worth $445M, up 1.6% from $438M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Kurt F. Somerville's Q2 2016 filing shows 2 new, 33 increased, 33 reduced and 4 closed positions. Its largest new stake was Empire State Realty Series ES: 11,000 shares worth $208K. The largest sale was EMC CORPORATION, an estimated $2.9M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Kurt F. Somerville's largest Q2 2016 buy was Empire State Realty Series ES: 11,000 shares worth $208K.
  • Kurt F. Somerville added most to Danaher in Q2 2016, an estimated $2.24M increase.
  • Kurt F. Somerville's biggest Q2 2016 reduction was EMC CORPORATION, cutting an estimated $2.9M.
  • Kurt F. Somerville fully exited Monsanto Co in Q2 2016, selling an estimated $336K.
  • Kurt F. Somerville's ten largest holdings make up 39% of its $445M portfolio in Q2 2016.
  • Kurt F. Somerville opened 2 new positions and closed 4 in Q2 2016.
  • Kurt F. Somerville's portfolio value rose 1.6% quarter-over-quarter to $445M.

Based on Kurt F. Somerville's 13F filing for Q2 2016, filed 8 Aug 2016.